The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,4-Diamino-6-(1-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazol-4-yl)-quinazoline ID: ALA5183436
PubChem CID: 163214076
Max Phase: Preclinical
Molecular Formula: C19H19N7O3
Molecular Weight: 393.41
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(-n2cc(-c3ccc4nc(N)nc(N)c4c3)nn2)cc(OC)c1OC
Standard InChI: InChI=1S/C19H19N7O3/c1-27-15-7-11(8-16(28-2)17(15)29-3)26-9-14(24-25-26)10-4-5-13-12(6-10)18(20)23-19(21)22-13/h4-9H,1-3H3,(H4,20,21,22,23)
Standard InChI Key: SWULRQWLALOGFO-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
-3.2447 -1.5425 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.9579 -1.1278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9579 -0.3069 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.2447 0.1077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5315 -0.3069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8183 0.1077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1050 -0.3069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1050 -1.1278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8183 -1.5425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5315 -1.1278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9102 0.3856 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4996 1.0987 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3048 0.9246 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3919 0.1077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3585 -0.2280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7312 0.2943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0629 -0.4561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8839 -0.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3691 0.1243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0332 0.8790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2163 0.9619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5184 1.5425 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3394 1.4595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1859 0.0373 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6753 0.7048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2198 -1.2937 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0408 -1.3808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2447 0.9288 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.6753 -1.5425 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
1 10 2 0
5 10 1 0
11 12 1 0
12 13 2 0
13 14 1 0
7 14 1 0
14 15 2 0
11 15 1 0
11 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
16 21 2 0
20 22 1 0
22 23 1 0
19 24 1 0
24 25 1 0
18 26 1 0
26 27 1 0
4 28 1 0
2 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 393.41Molecular Weight (Monoisotopic): 393.1549AlogP: 2.07#Rotatable Bonds: 5Polar Surface Area: 136.22Molecular Species: NEUTRALHBA: 10HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.09CX LogP: 2.31CX LogD: 2.20Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.52Np Likeness Score: -1.02
References 1. Wang FC, Peng B, Ren TT, Liu SP, Du JR, Chen ZH, Zhang TT, Gu X, Li M, Cao SL, Xu X.. (2022) A 1,2,3-Triazole Derivative of Quinazoline Exhibits Antitumor Activity by Tethering RNF168 to SQSTM1/P62., 65 (22.0): [PMID:36331508 ] [10.1021/acs.jmedchem.2c00432 ]